Current Hypotheses and Research Milestones in Alzheimer's Disease /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer US : Imprint: Springer,
2009.
|
| Edición: | 1st ed. 2009. |
| Materias: |
Tabla de Contenidos:
- Amyloid-ß: General Aspects
- Role of A? Degrading Enzymes in Synaptic Plasticity and Neurogenesis in Alzheimer's Disease
- Pore-Forming Neurotoxin-Like Mechanism for A? Oligomer-Induced Synaptic Failure
- Interventions in Aging and Neurodegenerative Disease: Effects on Adult StemCells
- Neuronal Cytoskeleton and the Tau Hypothesis
- Tau Transgenic Mouse Models in Therapeutic Development
- What Have We Learned from the Tau Hypothesis?
- Neuronal Cytoskeleton Regulation and Neurodegeneration
- Stages of Pathological Tau-Protein Processing in Alzheimer's Disease: From Soluble Aggregations to Polymerization into Insoluble Tau-PHFs
- Plasma Membrane-Associated PHF-Core Could be the Trigger for Tau Aggregation in Alzheimer's Disease
- Oxidative Stress Hypothesis
- Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer's Disease
- Neuroimmunological Hypothesis
- Inflammatory Processes Exacerbate Degenerative Neurological Disorders
- Central Nervous System Inflammation and Cholesterol Metabolism Alterations in the Pathogenesis of Alzheimer's Disease and Their Diagnostic and Therapeutic Implications
- Participation of Glial Cells in the Pathogenesis of AD: A Different View on Neuroinflammation
- Cerebrovascular Pathology and AD
- Cerebral and Cardiac Vascular Pathology in Alzheimer's Disease
- Are Amyloids Infectious?
- The Possible Link Between Herpes Simplex Virus Type 1 Infection and Neurodegeneration
- General Aspects of AD Pathogenesis
- Selective Cerebrocortical Regional, Laminar, Modular and Cellular Vulnerability and Sparing in Alzheimer's Disease: Unexploited Clues to Pathogenesis, Pathophysiology, Molecular- and Systems-Level Hypothesis Generation and Experimental Testing
- How Biochemical Pathways for Disease May be Triggered by Early-Life Events
- Biomarkers and AD
- Strategies for Alzheimer's Disease Diagnosis
- Cognitive Neurology in AD
- The Diagnosis of Dementia in Subjects with Heterogeneous Educational Levels
- Current Anti-Dementia Drugs: Hypothesis and Clinical Benefits.